logo

For the Inventor, By the Inventor

Nutley, NJ, United States of America

Eisai Inc.


USPTO Granted Patents = 33



Trademarks = 26

Forward Citations = 150

Loading Chart...
Loading Chart...

81 inventors (with patents filed for the assignee):

goldMedal Jie Zhang (9 out of 37 patents)

silverMedal Weizheng Xu (8 out of 14 patents)

bronzeMedal Dana Victor Ferraris (7 out of 18 patents)

4.  Gregory S Hamilton (6 out of 97 patents)

5.  Bridget Duvall (6 out of 10 patents)

6.  Greg Delahanty (6 out of 6 patents)

7.  Nicholas C Nicolaides (5 out of 87 patents)

8.  Luigi Grasso (4 out of 71 patents)

9.  Mark Vaal (4 out of 6 patents)

10.  Philip M Sass (4 out of 58 patents)

11.  Sergei Belyakov (4 out of 5 patents)

12.  Vincent Jacob Kalish (3 out of 52 patents)

13.  Takashi Tsukamoto (3 out of 22 patents)

14.  Jia-He Li (3 out of 44 patents)

15.  Amy Xing (2 out of 10 patents)


33 patents:

1. 11826399 - Chlorotoxin agents and uses thereof (2023-11-28),
2. 10539565 - Methods for determining prognosis of colorectal cancer (2020-01-21),
3. 10509037 - Monoclonal antibodies that specifically block biological activity of a tumor antigen (2019-12-17),
4. 10364284 - High affinity antibodies that neutralizeenterotoxin B (2019-07-30),
5. 10253106 - Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells (2019-04-09),
6. 10221240 - Methods for treatment of gastric cancer (2019-03-05),
7. 10053509 - Methods for inhibiting the binding of endosialin to ligands (2018-08-21),
8. 8894989 - PARP inhibitor compounds, compositions and methods of use (2014-11-25),
9. 8883787 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP (2014-11-11),
10. 8618075 - Certain compounds, compositions and methods (2013-12-31),
11. 8609640 - Multikinase inhibitors for use in the treatment of cancer (2013-12-17),
12. 8609631 - Compositions and methods for treating cancer (2013-12-17),
13. 8470825 - Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting PARP (2013-06-25),
14. 8329666 - Compositions and methods for treating cancer (2012-12-11),
15. 8329665 - Compositions and methods for treating cancer (2012-12-11),
Eisai Inc. is a pharmaceutical company dedicated to providing innovative solutions to address unmet medical needs. With a focus on neurology and oncology, Eisai is committed to improving the lives of patients worldwide. Through research and development, Eisai strives to bring groundbreaking therapies to market and make a positive impact on global health.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#1 in Nutley, NJ

#405 in New Jersey

#9,948 in US

#19,556 in the World

...
Nutley, NJ, United States of America

Eisai Inc.

Forward Citations = 150

81 inventors:

goldMedal Jie Zhang (9 out of 37 patents)

silverMedal Weizheng Xu (8 out of 14 patents)

bronzeMedal Dana Victor Ferraris (7 out of 18 patents)

4.  Gregory S Hamilton (6 out of 97 patents)

5.  Bridget Duvall (6 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…